Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan C Scott

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
JCO Precision Oncology|July 1, 2026
Emergence of Microsatellite Instability in an Oncogene-Driven Non-Small Cell Lung Cancer Harboring a Canonical <i>EGFR</i> Mutation: A Molecular Tumor Board DiscussionIlias Ziakas, Amna Jamali, Michael Conroy, et al.
JTO Clinical and Research Reports|July 8, 2024
First-line Osimertinib for Lung Cancer With Uncommon EGFR Exon 19 Mutations and EGFR Compound MutationsTia Cheunkarndee, Matthew Z Guo, Stefanie Houseknecht, et al.
AIDS Research and Therapy|May 18, 2023
Translocation of bacterial LPS is associated with self-reported cognitive abilities in men living with HIV receiving antiretroviral therapyStéphane Isnard, Léna Royston, Susan C Scott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2023
Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung CancerLavanya Sivapalan, Wade T Iams, Zineb Belcaid, et al.
Clinical Rehabilitation|January 29, 2015
Getting on with the rest of your life following stroke: a randomized trial of a complex intervention aimed at enhancing life participation post strokeNancy E Mayo, Sharon Anderson, Ruth Barclay, et al.
RMD Open|November 1, 2023
Improved lung cancer clinical outcomes in patients with autoimmune rheumatic diseasesPaola Ghanem, Joseph C Murray, Kristen A Marrone, et al.
Frontiers in Oncology|August 22, 2022
Sex-specific differences in immunogenomic features of response to immune checkpoint blockadeSusan C Scott, Xiaoshan M Shao, Noushin Niknafs, et al.
Cancer Research Communications|April 19, 2026
Serial Plasma Comprehensive Genomic Profiling Captures Therapy Resistance and Guides Management of Non-Small Cell Lung CancerMichael Conroy, Jaime Wehr, Vivian V Altiery De Jesus, et al.
Journal of Neuro-Oncology|July 16, 2025
Distinct size and spatial distribution patterns of ALK-inhibitor-naïve versus ALK-inhibitor exposed ALK-positive NSCLC brain metastasesTia Cheunkarndee, Zsombor Ritter, Max Saint-Germain, et al.
Cancer Research Communications|February 26, 2024
Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLCMari Nakazawa, Guilherme Harada, Paola Ghanem, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
JCO Precision Oncology|July 1, 2026
Emergence of Microsatellite Instability in an Oncogene-Driven Non-Small Cell Lung Cancer Harboring a Canonical <i>EGFR</i> Mutation: A Molecular Tumor Board DiscussionIlias Ziakas, Amna Jamali, Michael Conroy, et al.
JTO Clinical and Research Reports|July 8, 2024
First-line Osimertinib for Lung Cancer With Uncommon EGFR Exon 19 Mutations and EGFR Compound MutationsTia Cheunkarndee, Matthew Z Guo, Stefanie Houseknecht, et al.
AIDS Research and Therapy|May 18, 2023
Translocation of bacterial LPS is associated with self-reported cognitive abilities in men living with HIV receiving antiretroviral therapyStéphane Isnard, Léna Royston, Susan C Scott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2023
Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung CancerLavanya Sivapalan, Wade T Iams, Zineb Belcaid, et al.
Clinical Rehabilitation|January 29, 2015
Getting on with the rest of your life following stroke: a randomized trial of a complex intervention aimed at enhancing life participation post strokeNancy E Mayo, Sharon Anderson, Ruth Barclay, et al.
RMD Open|November 1, 2023
Improved lung cancer clinical outcomes in patients with autoimmune rheumatic diseasesPaola Ghanem, Joseph C Murray, Kristen A Marrone, et al.
Frontiers in Oncology|August 22, 2022
Sex-specific differences in immunogenomic features of response to immune checkpoint blockadeSusan C Scott, Xiaoshan M Shao, Noushin Niknafs, et al.
Cancer Research Communications|April 19, 2026
Serial Plasma Comprehensive Genomic Profiling Captures Therapy Resistance and Guides Management of Non-Small Cell Lung CancerMichael Conroy, Jaime Wehr, Vivian V Altiery De Jesus, et al.
Journal of Neuro-Oncology|July 16, 2025
Distinct size and spatial distribution patterns of ALK-inhibitor-naïve versus ALK-inhibitor exposed ALK-positive NSCLC brain metastasesTia Cheunkarndee, Zsombor Ritter, Max Saint-Germain, et al.
Cancer Research Communications|February 26, 2024
Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLCMari Nakazawa, Guilherme Harada, Paola Ghanem, et al.
Pageof 5